ZeptoMetrix Corporation and HarkerBIO, L.L.C. Form Strategic Collaboraton
ZeptoMetrix Corporation and HarkerBIO, L.L.C. Form Strategic Collaboraton
ZeptoMetrix and HarkerBIO announce the formation of an alliance for the development and commercialization of unique recombinant proteins. First joint venture is in response to tropical diseases.
Buffalo, NY
ZeptoMetrix™ Corporation, an industry leader and innovator for Infectious Disease Diagnostics and Development, announced today a broad, strategic collaboration with HarkerBIO for the development of unique recombinant proteins critical to tropical disease. HarkerBIO, known for its high success rate with challenging protein targets, is a premier partner for pharma and biotech companies with structure based drug discovery programs.
Under this broad research, development and commercialization alliance, HarkerBIO (https://www.harkerbio.com) will combine its extensive background in the design and development of various recombinant proteins with ZeptoMetrix™ (https://www.zeptometrix.com), who in turn, will lev

